Clinical Trials Logo

Threatened Miscarriage clinical trials

View clinical trials related to Threatened Miscarriage.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06011057 Completed - Clinical trials for Threatened Miscarriage

Evaluation of Serum Levels of C Reactive Protein (CRP) and Its Correlation With Fetal Ultrasound Parameters in the Prediction of Threatened Miscarriage in the First Trimester

Start date: July 1, 2022
Phase:
Study type: Observational

The goal of this observational study is to evaluate and compare in pregnant women with threatened miscarriage in the first trimester. The main questions it aims to answer are: What is the correlation between serum C reactive protein (CRP) levels and fetal ultrasound parameters in predicting threatened miscarriage? How accurate are serum C reactive protein (CRP) levels versus ultrasound in predicting pregnancy loss in threatened miscarriage? Participants will have blood tests to measure C reactive protein (CRP) levels and fetal ultrasound exams to assess parameters like crown-rump length. Researchers will compare serum C reactive protein (CRP) levels and fetal ultrasound findings to see if either or both can accurately predict pregnancy loss in women with first trimester threatened miscarriage.

NCT ID: NCT03358940 Completed - Clinical trials for Threatened Miscarriage

Assessment of Non-medical Use of Misoprostol in Case of Miscarriage or Threatened Miscarriage.

MISO
Start date: March 29, 2016
Phase: N/A
Study type: Interventional

Non-medical used of misoprostol for abortion is a growing concern in Guadeloupe. Such situation is reasonable for countries in which abortion is not easy to obtain or prohibited. However regarding the risk of complications, it is less understandable in region like Guadeloupe where legal abortion with medical assistance is accessible for all and free. The aim of the study is to investigate on the amount of misoprostol taken by women in Guadeloupe, by doing an analytical measurement. The aim is to evaluate batter this practice in Guadeloupe, when the main objective of the study is to detect the presence or the absence of misoprostol in the urine sample of the woman coming at hospital for threatened miscarriage or miscarriage complications. Moreover, these abortions can be more important than spontaneous miscarriage.

NCT ID: NCT03309735 Completed - Clinical trials for Threatened Miscarriage

Non-interventional Study of Therapy for Threatened Miscarriage

Start date: October 16, 2017
Phase: N/A
Study type: Observational

Study the efficacy and safety of therapy for threatened miscarriage with medicinal products Utrogestan (micronized progesterone), 200 mg capsules (Besins Healthcare SA, Belgium), and Duphaston (Dydrogesterone), 10 mg coated tablets (Abbott Healthcare Products B.V., the Netherlands)